Turkish Society for Rheumatology recommendations for the diagnosis, follow-up and management of giant cell arteritis

Key Points

This research aims to provide recommendations for the diagnosis and treatment of giant cell arteritis (GCA).
Assessment of various treatment options for GCA, including immunosuppressives and biologic agents.
Evaluation of the effectiveness and safety of upadacitinib for elderly patients with high cardiovascular risk.
Conventional immunosuppressives are identified as cost-effective options for GCA treatment.
Upadacitinib shows promise as a new treatment strategy, but more real-life data on safety is needed for the elderly.

Guidelines propose management strategies for giant cell arteritis, suggesting cost-effective treatments and safer options for elderly patients.

No takes yet. Share an insight, caveat, or question.

Alibaz-Oner et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Share